CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)

ObjectiveTranslocation (11;14) is one of the most frequent recurrent cytogenetic abnormalities in multiple myeloma (MM), while its clinical prognostic value remains controversial. CD20 expression is uncommon in MM while strongly associated with t(11;14). This study aimed to investigate whether CD20...

Full description

Bibliographic Details
Main Authors: Yuan Jian, Zhiyao Zhang, Huixing Zhou, Guangzhong Yang, Chuanying Geng, Huijuan Wang, Wen Gao, Wenming Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
CD20
t(11;14)
prognosis
survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1061438/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1061438/full

Similar Items